Myopathy and alterations in serum 3-methylhistidine in dogs with liver disease

Research in Veterinary Science

Volumn 84, Issue 2, 2008, Pages 178-184

  Neumann, Stephan ^a   Welling, Heike ^a   Bilzer, Thomas ^b   Thuere, Sibylle ^c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c Vet Med Labor GmbH   (Germany)

Author keywords

3 methylhistidine; Dog; Liver disease; Myopathy

Indexed keywords

3 METHYLHISTIDINE; CREATINE KINASE;

AMINO ACID BLOOD LEVEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DOG; ELECTROMYOGRAPHY; ENZYME ACTIVITY; FEMALE; HEPATITIS; HISTOPATHOLOGY; LIVER DISEASE; LIVER TUMOR; MALE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; NONHUMAN; STATISTICAL SIGNIFICANCE;

ANIMALS; DOG DISEASES; DOGS; LIVER DISEASES; METHYLHISTIDINES; MUSCLE, SKELETAL; MUSCULAR DISEASES;

CANIS FAMILIARIS;

EID: 36849043625     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2007.05.014     Document Type: Article

References (31)

1. Blaise P., Moonen M., and Rorive G. Update on hepatorenal syndrome. Nephrologie. 23 (2002) 11-17
2. Bilzer T. Diagnostic biopsy of muscular diseases in dogs. Prakt. Tierarzt 82 (2001) 424-430
3. Braund K.G. Nerve and muscle biopsy techniques. Prog. Vet. Neurol. 2 (1991) 35-56
4. Chinkes D.L. Methods for measuring tissue protein breakdown rate in vivo. Curr. Opin. Clin. Nutr. Metab. Care. 8 (2005) 534-537
5. Crawford D.H.G., Shepard R.W., Halliday J.W., Cooksley G.W., Golding S.D., Cheng W.S.C., and Powell L.W. Body composition in non alkoholic cirrhosis. Gastroenterology 106 (1994) 1611-1671
6. Dill-Macky E. Chronisch hepatitis in dogs. Vet. Clin. North Am. 25 (1995) 387-398
7. Frost R.A., and Lang C.H. Regulation of insulin-like growth factor I in skeletal muscle and muscle cells. Minerva Endocrinol. 28 (2003) 53-73
8. Gaschen F. In: Kessler M. (Ed). Paraneoplastische Syndrome (1999), Kleintieronkologie. Verlag Parey, Berlin, Wien
9. Gerok W., Roessle M., and Schoelmerich J. Leberzirrhose. In: Gerok W., and Blum H.E. (Eds). Hepatologie (1995), Urban and Schwarzenberg, München
10. Gines P., Guevara M., Arroyo V., and Rodes J. Hepatorenal syndrome. Lancet 362 (2003) 1819-1827
11. Hilgard P., and Gerken G. Hepatic encephalopathy. Med. Klin. 99 (2004) 591-602
12. Holt R.I.G., Jones J.S., Stone N.M., Baker A.J., and Miell J.P. Sequential changes in insulin-like growth factor I and insulin-like growth factor binding proteins in children with end stage liver disease before and after successful orthotopic liver transplantation. J. Clin. Endocrinol. Metabol. 81 (1996) 160-168
13. Hoppel C.L., and Davis A.T. Inter-tissue relationships in the synthesis and dis- insufficiency. Clin. Chem. 23 (1977) 278-280
14. Levy V.G., Cameron E., Ollat H., Opolon P., Darnis F., and Contamin F. Chronic hepatic encephalopathies. Acquired cerebral degeneration not due to Wilson's disease. Sem. Hop. 59 (1983) 1369-1373
15. Marchesini G., Zoli M., Angiolini A., Dondi C., Bianchi F.B., and Pisi E. Muscle protein breakdown in liver cirrhosis and the role of altered carbohydrate metabolism. Hepatology 1 (1981) 294-299
16. Morrison W.L., Bouchier I.A.D., Gibson J.N.A., and Renie M.J. Skeletal muscle and whole body protein turnover in cirrhosis. Clin. Sci. 78 (1990) 613-619
17. Nagasawa T., Yoshizawa F., and Nishizawa N. Plasma N tau-N-methylhistidine concentration is a sensitive index of myofibrillar protein degradation during starvation in rats. Biosci. Biotechnol. Biochem. 60 (1996) 501-512
18. Owen O.E., Reichle F.A., Mazzoli A., Kreulen M.S., Patel I.B., Elfenbein M., Golsorkhi K.H., Chang N.S., Sue U., and Boden G. Hepatic, gut and renal substrate flux rates in patients with hepatic cirrhosis. J. Clin. Invest. 68 (1981) 240-252
19. Planas R., Bataller R., and Rodes J. Hepatorenal Syndrome. Curr. Treat. Options Gastroenterol. 3 (2000) 445-450
20. Rathmacher J.A., Flakoll P.J., and Nissen S.L. A compartmental model of 3-N-methylhistidine metabolism in humans. Am. J. Physiol. 269 (1995) 193-198
21. Rathmacher J.A., and Nissen S.L. Development and application of a compartmental model of 3-N-methylhistidine metabolism in humans and domestic animals. Adv. Exp. Med. Biol. 445 (1998) 303-324
22. Rothuizen J., and Van Den Ingh T.S. Hepatitis in dogs; a review. Tijdschr Diergeneeskd 15 (1998) 246-252
23. Shmueli E., Stewart M., Alberti K.G., and Record C.O. Growth hormone, insulin-like growth factor I and insulin resistance in cirrhosis. Hepatology 19 (1994) 322-328
24. Szewczyk N.J., and Jacobson L.A. Signal-transduction networks and the regulation of muscle protein degradation. Int. J. Biochem. Cell Biol. 37 (2005) 1997-2011
25. Teske E., Rothuizen J., De Bruijne J.J., and Mol J.A. Separation and heat stability of the corticosteroid-induced and hepatic alkaline phosphatase isoenzymes in canine plasma. J. Chromatogr. 21 (1986) 349-356
26. Thompson M.G., Palmer R.M., Thom A., Mackie S.C., Morrison K.S., and Harris C.I. Measurement of protein degradation by release of labelled 3-N-methylhistidine from skeletal muscle and non-muscle cells. J. Cell Physiol. 166 (1996) 506-511
27. Twedt D.C. Reactive hepatopathies and chronic hepatitis in the dog. Vet. Q. 20 (1998) 46-47
28. Young V.R., Alexis S.D., Baliga B.S., Munro H.N., and Mueck W. Metabolism of administered 3-N-methylhistidine. Lack of muscle transfer ribonucleic acid charging and quantitative excretion as 3-N-methylhistidine and its N-acetyl derivative. J. Biol. Chem. 247 (1972) 3592-3600
29. Young V.R., and Munro H.N. N tau-N-methylhistidine (3-N-methylhistidine) and muscle protein turnover: an overview. Fed. Proc. 37 (1978) 2291-2300
30. Wettstein M., Kircheis G., and Haussinger D. Hepatic encephalopathy-diagnostics. Dtsch. Med. Wochenschr. 128 (2003) 2654-2657
31. Zentek J. Diätetik bei Hunden und Katzen mit tumorösen Erkrankungen. Kleintierpraxis 41 (1996) 571-583